Document is current
Any future updates will be listed below
-
Authors
Smit, Lisa
Slooter, Arjen J. C.
Devlin, John W.
Trogrlic, Zoran
Hunfeld, Nicole G. M.
Osse, Robert Jan
Ponssen, Huibert H.
Brouwers, Arjen J. B. W.
Schoonderbeek, Jeannette F.
Simons, Koen S.
van den Boogaard, Mark
Lens, Judith A.
Boer, Dirk P.
Gommers, Diederik A. M. P. J.
Rietdijk, Wim J. R.
van der Jagt, Mathieu
,
-
Clinical Trials BETA
Clinical trials referenced in this document:
nct03628391 at ClinicalTrials.govDocuments that mention this clinical trial
Efficacy of halopeRIdol to decrease the burden of Delirium In adult Critically ill patiEnts (EuRIDICE): study protocol for a prospective randomised multi-centre double-blind placebo-controlled clinical trial in the Netherlands (Pre-results)
https://doi.org/10.1136/bmjopen-2019-036735
Efficacy of haloperidol to decrease the burden of delirium in adult critically ill patients: the EuRIDICE randomized clinical trial
https://doi.org/10.1186/s13054-023-04692-3
-
Funding
Funding for this research was provided by:
ZonMw (848041001)
- License Information
-
More Information
Article History
Received: 6 August 2023
Accepted: 18 October 2023
First Online: 30 October 2023
Declarations
:
: The study protocol was approved by the Medical Ethics Committees of all participating hospitals and has been published []. The study was conducted according to the principles of the Declaration of Helsinki and in accordance with the Medical Research Involving Human Subjects Act (WMO) and other guidelines, regulations and Acts. Eligible patients or their legal representatives were asked for written informed consent as soon as possible after ICU admission to enable randomization as soon as possible after delirium was first diagnosed.
: Not applicable.
: The authors declare that they have no competing interests.
